How much more weight can you lose with Retatrutide vs Semaglutide?

Clinical trials show Retatrutide produces 24-29% body weight loss at 48-68 weeks vs 15-17% for Semaglutide. That

When will Retatrutide be FDA approved?

Retatrutide is currently in Phase 3 clinical trials (TRIUMPH program). Based on trial timelines, FDA approval could potentially come in late 2026 or 2027. Until then, it

Are the side effects similar?

Both medications share similar GI side effects: nausea (most common), diarrhea, constipation, and vomiting. Retatrutide users report stronger appetite shifts and occasionally more digestive sensitivity due to the triple-pathway activation. However, discontinuation rates are similar (~14% for GLP-1 class).

Should I wait for Retatrutide or start Semaglutide now?

This depends on your situation. Choose Semaglutide if you want proven, FDA-approved treatment available now with insurance coverage and extensive safety data. Consider waiting for (or accessing) Retatrutide if you

Can I switch from Semaglutide to Retatrutide?

When Retatrutide becomes available, switching may be possible under medical supervision. Both are weekly injections, but the transition would need to be carefully managed due to the different receptor profiles. Consult with your healthcare provider about timing and protocol.

PeptideKey Research Library

GLP-1 Choice: Semaglutide Evidence — 70 Human RCTs

Compare Retatrutide and Semaglutide for research. Explore their mechanisms, potential benefits, and safety considerations based on current evidence.

This research guide is part of PeptideKey's evidence-based peptide research library covering 100+ compounds with lab-verified purity data.